STOCKHOLM, April 14, 2021 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Johan Aschan as Chief Medical Officer, effective July 1st. He will be member of the company's management team. Dr. Aschan received his MD from Karolinska Institutet (KI) in 1985...